COMMUNIQUÉS West-GlobeNewswire

Philips-led projects win ITEA awards for advancing AI-enabled healthcare innovation
16/09/2026
September 16, 2026 SYMPHONY receives ITEA’s highest excellence award for connected healthcare ecosystems AI FORSchung is recognized for innovation in AI-powered fiber-optic sensing Amsterdam, the Netherlands – Royal [...]
R1 Expands Phare OS with Phare UM, Bringing Real-Time Payer Risk Intelligence to Utilization Management
16/09/2026
The Guthrie Clinic is Among the First Health Systems Adopting the New AI-enabled Solution to Identify Clinical Status Risk Earlier and Reduce Avoidable Medical Necessity Denials CHICAGO, Sept. 16, 2026 (GLOBE NEWSWIRE [...]
Syneos Health and Tufts CSDD Study Shows Clinical Trial Performance Depends More on Operating Model Design Than Sourcing Strategy
16/09/2026
Data From 13 Leading Pharmaceutical Companies Points to Execution, Governance and Partner Coordination as Key Drivers of Trial Performance MORRISVILLE, N.C., Sept. 16, 2026 (GLOBE NEWSWIRE) -- Syneos Health®, a leading [...]
Myriad Genetics Appoints Vishal Sikri Executive Vice President - Commercial
16/09/2026
SALT LAKE CITY, Sept. 16, 2026 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc. , (NASDAQ: MYGN), a leader in molecular diagnostic testing and precision medicine, today announced that Vishal Sikri has been promoted to [...]
Seer Surpasses 100 Peer-Reviewed Customer Publications, Validating a New Era of Deep Proteomics at Scale
16/09/2026
Six years after Seer’s foundational Nature Communications paper, researchers across three continents have built a growing body of evidence demonstrating the power of deep, unbiased proteomics across genetics, aging, [...]
Novo and Anthropic will collaborate to advance drug discovery with Claude
16/09/2026
Collaboration aims to help Novo discover and develop new medicines faster Novo will use Anthropic models and Claude Science to advance scientific reasoning for Research and Development (R&D) and agentic software [...]
Teva Launches LongActingImpact.com to Advance Understanding of Earlier, Effective and Uninterrupted Schizophrenia Care
16/09/2026
L ong-acting inject ables (LAIs) offer an opportunity to improve adherence and potential outcomes for patients with schizophrenia LongActingImpact.com is a new resource center designed to support clinicians in having [...]
Odyssey Therapeutics to Participate in Stifel 2026 Virtual Immunology and Inflammation Forum
16/09/2026
BOSTON, Sept. 16, 2026 (GLOBE NEWSWIRE) -- Odyssey Therapeutics, Inc. (Nasdaq: ODTX) (“Odyssey” or the “Company”), a clinical-stage biopharmaceutical company seeking to transform the standard of care for patients [...]
Exicure Receives Nasdaq Extension to Regain Compliance with Stockholders’ Equity Requirement
16/09/2026
WILMINGTON, Del., Sept. 16, 2026 (GLOBE NEWSWIRE) -- Exicure, Inc. (Nasdaq: XCUR) (“Exicure” or the “Company”) today announced that, on September 10, 2026, it received a letter from the Listing Qualifications Department [...]
Stereotaxis Emerging Digital, AI and Automation Capabilities to be Featured at Heart Rhythm Society’s HRX 2026
16/09/2026
New digital technologies, including Synchrony and SynX, will be featured at HRX Stereotaxis CEO to join main-stage panel on Autonomous EP Systems ST. LOUIS, Sept. 16, 2026 (GLOBE NEWSWIRE) -- Stereotaxis (NYSE: STXS), a [...]
Dr. Peter Goldman Returns to the Bay Area, Bringing Zone Technique and a Distinct Approach to Healing to Berkeley, CA
16/09/2026
Founder of Zone School of Healing Uses the Zone Technique to Balance the Body’s Six Main Systems, Helping Clients Pursue Healing at the Highest Level BERKELEY, CA, Sept. 16, 2026 (GLOBE NEWSWIRE) -- After nearly a [...]
X-Chem Named First Winner of Chordoma Foundation TBXT Challenge with Discovery of Novel Binder for Untreatable Bone Cancer Target
16/09/2026
Groundbreaking synergy of DEL screening and computational chemistry yields the first compound to meet the TBXT Challenge’s submicromolar binding threshold for brachyury (TBXT) WALTHAM, Mass., Sept. 16, 2026 (GLOBE [...]
NEXGEL Announces Date for Investor Update Call
16/09/2026
LANGHORNE, Pa., Sept. 16, 2026 (GLOBE NEWSWIRE) -- NEXGEL, Inc. ("NEXGEL" or the "Company") (NASDAQ: "NXGL"), a company with a patient centric medical technology sales and marketing team working closely with clinicians [...]
PETVIVO ANIMAL HEALTH, INC. RELEASES CONFERENCE AND EXHIBIT SCHEDULE FOR 2026-2027
16/09/2026
MINNEAPOLIS, Sept. 16, 2026 (GLOBE NEWSWIRE) -- PetVivo Animal Health, Inc. ("PetVivo"), in cooperation with its parent, PetVivo Holdings, Inc. (OTCQX: PETV), and its other subsidiaries, Somatrix Technologies, Inc. and [...]
Impact Biomedical Inc Announces Filing of Form F-4 Registration Statement in Connection with Proposed Merger with Zoar Ltd. (f/k/a Dr. Ashley’s Limited)
16/09/2026
HOUSTON, Sept. 16, 2026 (GLOBE NEWSWIRE) -- Impact Biomedical Inc. (NYSE: IBO) (the “ Company ” or “ Impact ”) announced that a Form F-4 registration statement (the “ Registration Statement ”) was filed with the U.S. [...]
NeurAxis Announces Medical Coverage Policy Milestone, Expanding Access to Over 18 million additional Covered Lives
16/09/2026
Total national coverage footprint for PENFS increases to over 120 million covered lives CARMEL, Ind., Sept. 16, 2026 (GLOBE NEWSWIRE) -- NeurAxis, Inc. (“NeurAxis” or the “Company”) (NYSE American: NRXS), a medical [...]
NeuroSigma Expands Payment Options for the Monarch eTNS® System
16/09/2026
Families prescribed Monarch can now pay with digital wallets or third-party installment plans at checkout LOS ANGELES, Sept. 16, 2026 (GLOBE NEWSWIRE) -- NeuroSigma, Inc. today announced expanded payment options for [...]
ESA Letter in Utah: RealESALetter.com Gains Recognition Among Utah Residents
16/09/2026
SALT LAKE CITY, UT, Sept. 16, 2026 (GLOBE NEWSWIRE) -- RealESALetter.com connects Utah residents with licensed mental health professionals for individualized emotional support animal (ESA) evaluations and documentation [...]
Abeona Therapeutics® Announces Activation of University of Florida Health as Newest Qualified Treatment Center for ZEVASKYN®
16/09/2026
CLEVELAND, Sept. 16, 2026 (GLOBE NEWSWIRE) -- Abeona Therapeutics Inc. (Nasdaq: ABEO), a commercial-stage biopharmaceutical company developing genetic medicines for serious diseases with high unmet need, today announced [...]

Pages